3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
238
Lymphoma
235
Lymphoma, Non-Hodgkin
203
Leukemia, Lymphocytic, Chronic, B-Cell
186
Lymphoma, Large B-Cell, Diffuse
178
Lymphoma, Follicular
173
Lymphoma, B-Cell
112
Lymphoma, Mantle-Cell
107
Hodgkin Disease
105
Leukemia, Myeloid, Acute
102
Recurrence
97
Multiple Myeloma
91
Burkitt Lymphoma
90
Leukemia
76
Neoplasms
68
Lymphoma, B-Cell, Marginal Zone
60
Hematologic Neoplasms
59
Myelodysplastic Syndromes
56
Waldenstrom Macroglobulinemia
48
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
43
Lymphoma, T-Cell
42
Lymphoma, T-Cell, Peripheral
36
Lymphoma, T-Cell, Cutaneous
31
Leukemia, Biphenotypic, Acute
31
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
29
Leukemia, B-Cell
26
Mycosis Fungoides
25
Lymphoma, Large-Cell, Anaplastic
25
Sarcoma
23
Breast Neoplasms
22
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemostatic Disorders
×
Lymphoid
×
90 days
×
Clear all
NCT07075185
2026-04-24
inMMyCAR
Kelonia Therapeutics, Inc.
Phase 1
Recruiting
70 enrolled